Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarshalls Regulatory News (MSLH)

Share Price Information for Marshalls (MSLH)

Share Price is delayed by 15 minutes
Get Live Data
131.60    -4.30 (-3.16%)
Bid:
131.30
Ask:
131.50
Spread: 0.20 (0.152%)
Market Cap: £332.80m
MSLH Live PriceLast checked at - London Stock Exchange

Intraday Marshalls Share Chart

Director/PDMR Shareholding

16 Mar 2007 15:48

Marshalls PLC16 March 2007 NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIALRESPONSIBILITY OR CONNECTED PERSONS On 16 March 2007 Marshalls plc was notified that, on that date, Marshalls EBTLimited, the Trustee of the Marshalls plc 2005 Employee Benefit Trust, purchased115,773 ordinary shares of 25 pence each in the Company at a price of 326 penceper share on behalf of Directors and Senior Executives who are participating inthe Marshalls plc 2005 Long Term Incentive Plan (the LTIP). Under the rules of the LTIP Directors and Senior Executives undertake to use apercentage of their bonus to purchase shares in the Company (Investment Shares)and, in return, are granted a Matching Share Award of Shares. Directors and Senior Executives have irrevocably committed to use a fixed sum ofmoney payable from their 2006 bonus to purchase Investment Shares and theCompany has granted them Matching Share Awards over such number of shares thatequals two times the number of shares that the Directors and Senior Executivescould have bought had the investment of his or her bonus been made on a pre-taxbasis. To be eligible to receive the Matching Share Award, the Directors and SeniorExecutives must leave their Investment Shares in the Trust and remain inemployment for a period of three years from the date of grant of the MatchingShare Award. The actual number of shares transferred to a Director or SeniorExecutive on the vesting of the Matching Share Award will depend on the extentto which a corporate performance target (which relates to growth in theCompany's earnings per share) is satisfied over the three year vesting period.Full details of the LTIP are provided in the Report on Directors' Remunerationin the Marshalls plc 2005 Annual Report. The following Directors and Senior Executives (being persons dischargingmanagerial responsibilities (PDMRs)) acquired interests in shares under theLTIP as follows: Number of Total Number of Investment beneficial shares granted Shares shareholding under Matching purchased following this Share Award announcementDirectorGraham Holden 48,279 293,950 163,657Ian Burrell 24,944 68,032 84,556David Sarti 23,514 57,306 79,707 PDMRElizabeth Blease 921 1,904 3,120Peter Hallitt 1,841 1,841 6,239Christopher Harrop 1,541 2,552 5,223Kevin Hull 921 2,973 3,120Michael Wignall 921 3,671 3,120 The Directors of Marshalls EBT Limited are David Graham Holden and Ian DavidBurrell who are Directors of the Company. David Graham Holden, Ian David Burrell and David Neil Sarti as Directors andElizabeth Blease, Peter Hallitt, Christopher Harrop, Kevin Hull and MichaelWignall as PDMRs are amongst the potential beneficiaries of the Trust and areregarded for Companies Act purposes as being interested in all the Marshalls plcordinary shares held by the Trust, although the shares held by the Trust arealso held for the benefit of other employees of the Company. Despite thetechnical interest in the shares, the Directors and PDMRs will only be entitledto receive that number of shares to which they would be entitled on exercise ofan award or option which has been granted to them. Enquiries: Elizabeth Blease, Company Secretary, Marshalls plc, 01484 438900 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
2nd Jun 20267:00 amRNSHolding(s) in Company
29th May 202612:17 pmRNSHolding(s) in Company
22nd May 20264:01 pmRNSDirector/PDMR Shareholding
22nd May 20263:58 pmRNSDirector/PDMR Shareholding
15th May 202611:04 amRNSDirector/PDMR Shareholding
15th May 202611:03 amRNSDirector/PDMR Shareholding
14th May 202610:05 amRNSDirector/PDMR Shareholding
14th May 202610:05 amRNSDirector/PDMR Shareholding
14th May 202610:05 amRNSDirector/PDMR Shareholding
14th May 202610:05 amRNSDirector/PDMR Shareholding
14th May 202610:05 amRNSDirector/PDMR Shareholding
13th May 20263:08 pmRNSResult of AGM
13th May 20267:00 amRNSAGM Trading Update
15th Apr 202612:17 pmRNSDirector/PDMR Shareholding
15th Apr 202612:15 pmRNSDirector/PDMR Shareholding
17th Mar 20263:01 pmRNSDirector/PDMR Shareholding
17th Mar 20262:59 pmRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSFinal Results
16th Mar 20267:00 amRNSFinal Results
11th Mar 20264:27 pmRNSDirector/PDMR Shareholding
11th Mar 20264:27 pmRNSDirector/PDMR Shareholding
11th Mar 20264:18 pmRNSDirector/PDMR Shareholding
11th Mar 20264:18 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNS-RNotice of Engage Investor Presentation
13th Feb 20263:21 pmRNSDirector/PDMR Shareholding
13th Feb 20263:04 pmRNSDirector/PDMR Shareholding
13th Feb 20263:04 pmRNSDirector/PDMR Shareholding
19th Jan 20267:01 amRNSTrading Statement
19th Jan 20267:00 amRNSDirectorate change
9th Jan 202612:40 pmRNSDirector/PDMR Shareholding
9th Jan 202612:38 pmRNSDirector/PDMR Shareholding
6th Jan 20269:36 amRNSNotice of Trading Update
9th Dec 20253:21 pmRNSDirector/PDMR Shareholding
27th Nov 20257:00 amRNSBoard changes
12th Nov 20257:00 amRNSTrading Update
10th Nov 202510:30 amRNSDirector/PDMR Shareholding
10th Nov 202510:29 amRNSDirector/PDMR Shareholding
10th Nov 202510:27 amRNSDirector/PDMR Shareholding
30th Oct 20259:01 amRNSNotice of Trading Update
9th Oct 202512:45 pmRNSDirector/PDMR Shareholding
9th Oct 202512:44 pmRNSDirector/PDMR Shareholding
9th Oct 202512:42 pmRNSDirector/PDMR Shareholding
10th Sep 202512:06 pmRNSDirector/PDMR Shareholding
10th Sep 202512:05 pmRNSDirector/PDMR Shareholding
10th Sep 202512:04 pmRNSDirector/PDMR Shareholding
12th Aug 20259:28 amRNSDirector/PDMR Shareholding
11th Aug 20251:57 pmRNSDirector/PDMR Shareholding
11th Aug 20257:00 amRNSHalf year results
7th Aug 20257:00 amRNSDirectorate Change
28th Jul 202512:26 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.